Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Usana Health Sciences Q2 2024 GAAP EPS $0.54 Misses $0.65 Estimate, Sales $212.869M Miss $221.032M Estimate

Author: Benzinga Newsdesk | July 23, 2024 04:17pm
Usana Health Sciences (NYSE:USNA) reported quarterly earnings of $0.54 per share which missed the analyst consensus estimate of $0.65 by 16.92 percent. The company reported quarterly sales of $212.869 million which missed the analyst consensus estimate of $221.032 million by 3.69 percent. This is a 10.64 percent decrease over sales of $238.202 million the same period last year.

Posted In: USNA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist